基础胰岛素临床应用常见问题指导建议——三十三问

2020-05-30 中华医学会糖尿病学分会 中华糖尿病杂志.2020.12(5):289-296.

针对我国临床医生使用目前国内已经上市的基础胰岛素中可能遇到的问题,以及目前我国使用基础胰岛素治疗的糖尿病患者达标率有待提高的现状,特撰写了本版基础胰岛素临床应用指导建议——三十

中文标题:

基础胰岛素临床应用常见问题指导建议——三十三问

发布日期:

2020-05-30

简要介绍:

针对我国临床医生使用目前国内已经上市的基础胰岛素中可能遇到的问题,以及目前我国使用基础胰岛素治疗的糖尿病患者达标率有待提高的现状,特撰写了本版基础胰岛素临床应用指导建议——三十三问,以问答的形式对基础胰岛素临床应用的常见问题进行解读,旨在为基础胰岛素的临床规范化使用、提高中国糖尿病治疗的整体血糖达标率和减少低血糖发生的风险、改善患者预后起到指导作用。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241052, encodeId=4a221241052fc, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4e26471690, createdName=ms5000001104745802, createdTime=Thu Aug 25 23:57:31 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224393, encodeId=4cfa12243930d, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145a8151059, createdName=ms4000002011291765, createdTime=Sat Jun 04 14:07:43 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999066, encodeId=179c999066be, content=扫盲, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Tue Jul 13 11:35:04 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977744, encodeId=28e09e7744a0, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/9d1b1de25b144368a8ef9f8d1aceecc6/d373d2d180c94ab2b004904cc746395e.jpg, createdBy=c5dc1873653, createdName=圈圈小圈, createdTime=Mon Jun 28 22:50:03 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974414, encodeId=4c8f9e4414ea, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/acf13560f19f47b587d88b0845f3ec0f/f6d84f97e1cd43b1acf9c3ec2d6af5d4.jpg, createdBy=ee401987986, createdName=丽丽酱, createdTime=Thu Jun 17 15:30:21 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2022-08-25 ms5000001104745802

    good

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241052, encodeId=4a221241052fc, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4e26471690, createdName=ms5000001104745802, createdTime=Thu Aug 25 23:57:31 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224393, encodeId=4cfa12243930d, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145a8151059, createdName=ms4000002011291765, createdTime=Sat Jun 04 14:07:43 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999066, encodeId=179c999066be, content=扫盲, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Tue Jul 13 11:35:04 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977744, encodeId=28e09e7744a0, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/9d1b1de25b144368a8ef9f8d1aceecc6/d373d2d180c94ab2b004904cc746395e.jpg, createdBy=c5dc1873653, createdName=圈圈小圈, createdTime=Mon Jun 28 22:50:03 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974414, encodeId=4c8f9e4414ea, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/acf13560f19f47b587d88b0845f3ec0f/f6d84f97e1cd43b1acf9c3ec2d6af5d4.jpg, createdBy=ee401987986, createdName=丽丽酱, createdTime=Thu Jun 17 15:30:21 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2022-06-04 ms4000002011291765

    好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241052, encodeId=4a221241052fc, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4e26471690, createdName=ms5000001104745802, createdTime=Thu Aug 25 23:57:31 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224393, encodeId=4cfa12243930d, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145a8151059, createdName=ms4000002011291765, createdTime=Sat Jun 04 14:07:43 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999066, encodeId=179c999066be, content=扫盲, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Tue Jul 13 11:35:04 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977744, encodeId=28e09e7744a0, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/9d1b1de25b144368a8ef9f8d1aceecc6/d373d2d180c94ab2b004904cc746395e.jpg, createdBy=c5dc1873653, createdName=圈圈小圈, createdTime=Mon Jun 28 22:50:03 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974414, encodeId=4c8f9e4414ea, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/acf13560f19f47b587d88b0845f3ec0f/f6d84f97e1cd43b1acf9c3ec2d6af5d4.jpg, createdBy=ee401987986, createdName=丽丽酱, createdTime=Thu Jun 17 15:30:21 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-07-13 木马🎠

    扫盲

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241052, encodeId=4a221241052fc, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4e26471690, createdName=ms5000001104745802, createdTime=Thu Aug 25 23:57:31 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224393, encodeId=4cfa12243930d, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145a8151059, createdName=ms4000002011291765, createdTime=Sat Jun 04 14:07:43 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999066, encodeId=179c999066be, content=扫盲, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Tue Jul 13 11:35:04 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977744, encodeId=28e09e7744a0, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/9d1b1de25b144368a8ef9f8d1aceecc6/d373d2d180c94ab2b004904cc746395e.jpg, createdBy=c5dc1873653, createdName=圈圈小圈, createdTime=Mon Jun 28 22:50:03 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974414, encodeId=4c8f9e4414ea, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/acf13560f19f47b587d88b0845f3ec0f/f6d84f97e1cd43b1acf9c3ec2d6af5d4.jpg, createdBy=ee401987986, createdName=丽丽酱, createdTime=Thu Jun 17 15:30:21 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-06-28 圈圈小圈

    好资料!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241052, encodeId=4a221241052fc, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4e26471690, createdName=ms5000001104745802, createdTime=Thu Aug 25 23:57:31 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224393, encodeId=4cfa12243930d, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=145a8151059, createdName=ms4000002011291765, createdTime=Sat Jun 04 14:07:43 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999066, encodeId=179c999066be, content=扫盲, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Tue Jul 13 11:35:04 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977744, encodeId=28e09e7744a0, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/9d1b1de25b144368a8ef9f8d1aceecc6/d373d2d180c94ab2b004904cc746395e.jpg, createdBy=c5dc1873653, createdName=圈圈小圈, createdTime=Mon Jun 28 22:50:03 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974414, encodeId=4c8f9e4414ea, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210617/acf13560f19f47b587d88b0845f3ec0f/f6d84f97e1cd43b1acf9c3ec2d6af5d4.jpg, createdBy=ee401987986, createdName=丽丽酱, createdTime=Thu Jun 17 15:30:21 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-06-17 丽丽酱

    0

拓展阅读

中国胰岛素泵治疗指南(2009)

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2010-01-19

2010 中国儿童及青少年糖尿病的胰岛素治疗指南

中华医学会儿科学分会内分泌遗传代谢学组 · 2010-06-01

2010 AACE 美国临床内分泌医师学会胰岛素泵专家共识

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2010-09-30

2011 ACP临床时间指南:住院患者使用胰岛素强化治疗的血糖控制管理

美国医师协会(ACP,American College of Physicians) · 2011-02-15

中国胰岛素泵治疗指南(2010)

中国医师协会内分泌代谢科医师分会 · 2011-03-20

成人2型糖尿病胰岛素临床应用中国专家共识2011

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2011-08-11